Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $117.10 million. The enterprise value is $160.73 million.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.66 million shares outstanding. The number of shares has decreased by -0.75% in one year.
| Current Share Class | 16.66M |
| Shares Outstanding | 16.66M |
| Shares Change (YoY) | -0.75% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 41.60% |
| Owned by Institutions (%) | 34.06% |
| Float | 9.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | 0.51 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | 16.45 |
| P/OCF Ratio | 10.65 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.96, with an EV/FCF ratio of 22.58.
| EV / Earnings | n/a |
| EV / Sales | 0.84 |
| EV / EBITDA | 16.96 |
| EV / EBIT | 40.40 |
| EV / FCF | 22.58 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.41.
| Current Ratio | 2.83 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 4.93 |
| Debt / FCF | 7.44 |
| Interest Coverage | 1.01 |
Financial Efficiency
Return on equity (ROE) is -4.50% and return on invested capital (ROIC) is 2.24%.
| Return on Equity (ROE) | -4.50% |
| Return on Assets (ROA) | 1.14% |
| Return on Invested Capital (ROIC) | 2.24% |
| Return on Capital Employed (ROCE) | 2.22% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | $281,945 |
| Profits Per Employee | -$8,699 |
| Employee Count | 678 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 2.75 |
Taxes
| Income Tax | -2.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.16% in the last 52 weeks. The beta is 0.72, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +53.16% |
| 50-Day Moving Average | 6.53 |
| 200-Day Moving Average | 6.63 |
| Relative Strength Index (RSI) | 49.07 |
| Average Volume (20 Days) | 26,096 |
Short Selling Information
The latest short interest is 80,003, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 80,003 |
| Short Previous Month | 91,018 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.82% |
| Short Ratio (days to cover) | 1.69 |
Income Statement
In the last 12 months, Ultralife had revenue of $191.16 million and -$5.90 million in losses. Loss per share was -$0.35.
| Revenue | 191.16M |
| Gross Profit | 46.02M |
| Operating Income | 3.98M |
| Pretax Income | -8.40M |
| Net Income | -5.90M |
| EBITDA | 9.48M |
| EBIT | 3.98M |
| Loss Per Share | -$0.35 |
Full Income StatementBalance Sheet
The company has $9.35 million in cash and $52.98 million in debt, giving a net cash position of -$43.64 million or -$2.62 per share.
| Cash & Cash Equivalents | 9.35M |
| Total Debt | 52.98M |
| Net Cash | -43.64M |
| Net Cash Per Share | -$2.62 |
| Equity (Book Value) | 130.13M |
| Book Value Per Share | 7.80 |
| Working Capital | 68.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $10.99 million and capital expenditures -$3.87 million, giving a free cash flow of $7.12 million.
| Operating Cash Flow | 10.99M |
| Capital Expenditures | -3.87M |
| Depreciation & Amortization | 5.50M |
| Net Borrowing | -4.75M |
| Free Cash Flow | 7.12M |
| FCF Per Share | $0.43 |
Full Cash Flow StatementMargins
Gross margin is 24.07%, with operating and profit margins of 2.08% and -3.09%.
| Gross Margin | 24.07% |
| Operating Margin | 2.08% |
| Pretax Margin | -4.39% |
| Profit Margin | -3.09% |
| EBITDA Margin | 4.96% |
| EBIT Margin | 2.08% |
| FCF Margin | 3.72% |